MapLight Therapeutics, Inc. (MPLT)
11.35
+0.14
(+1.25%)
USD |
NASDAQ |
Aug 24, 16:00
11.35
0.00 (0.00%)
After-Hours: 20:00
MapLight Therapeutics Shareholders Equity (Quarterly) : 348.30M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 348.30M |
| March 31, 2026 | 399.83M |
| December 31, 2025 | 458.37M |
| September 30, 2025 | 233.52M |
| Date | Value |
|---|---|
| June 30, 2025 | 63.76M |
| March 31, 2025 | 93.00M |
| June 30, 2024 | |
| March 31, 2024 | 172.83M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Evommune, Inc. | 277.59M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Cullinan Therapeutics, Inc. | 321.75M |
| Mineralys Therapeutics, Inc. | 550.92M |
| Apogee Therapeutics, Inc. | 1.195B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 368.35M |
| Total Liabilities (Quarterly) | 20.05M |
| Debt to Equity Ratio | 0.0057 |
| Current Ratio | 16.52 |
| Net Debt Paydown Yield | 0.05% |